Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rizwan Hamid

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
Urology Annals|August 11, 2017
Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivityChristina L Fontaine, Ian Rudd, Mahreen Pakzad, et al.
International Urogynecology Journal|July 29, 2020
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practiceRizwan Hamid, Maria-Fernanda Lorenzo-Gomez, Heinrich Schulte-Baukloh, et al.
The Journal of Urology|April 26, 2008
Ureterocystoplasty: long-term functional resultsNavroop S Johal, Rizwan Hamid, Zeeshan Aslam, et al.
Urology Annals|November 10, 2017
Preliminary report on the effect of urethral diverticulum magnetic resonance imaging configuration on the incidence of new onset urodynamic stress urinary incontinence following excisionSachin Malde, Sahar Naaseri, Rajesh Kavia, et al.
American Journal of Respiratory and Critical Care Medicine|September 26, 2018
The Y Chromosome Regulates BMPR2 Expression via SRY: A Possible Reason "Why" Fewer Males Develop Pulmonary Arterial HypertensionLing Yan, Joy D Cogan, Lora K Hedges, et al.
Pulmonary Circulation|May 25, 2019
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertensionJames D West, Xinping Chen, Ling Ping, et al.
Lower Urinary Tract Symptoms|October 10, 2017
Female bladder outlet obstruction: Common symptoms masking an uncommon causeSachin Malde, Eskinder Solomon, Marco Spilotros, et al.
Pharmacoeconomics|December 21, 2014
Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspectiveRizwan Hamid, Clara Loveman, Jim Millen, et al.
Neurourology and Urodynamics|June 24, 2020
The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature reviewBogdan Toia, Mahreen H Pakzad, Rizwan Hamid, et al.
The Journal of Clinical Investigation|April 1, 2022
Lessons learned: next-generation sequencing applied to undiagnosed genetic diseasesBryce A Schuler, Erica T Nelson, Mary Koziura, et al.
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Urology Annals|August 11, 2017
Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivityChristina L Fontaine, Ian Rudd, Mahreen Pakzad, et al.
International Urogynecology Journal|July 29, 2020
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practiceRizwan Hamid, Maria-Fernanda Lorenzo-Gomez, Heinrich Schulte-Baukloh, et al.
The Journal of Urology|April 26, 2008
Ureterocystoplasty: long-term functional resultsNavroop S Johal, Rizwan Hamid, Zeeshan Aslam, et al.
Urology Annals|November 10, 2017
Preliminary report on the effect of urethral diverticulum magnetic resonance imaging configuration on the incidence of new onset urodynamic stress urinary incontinence following excisionSachin Malde, Sahar Naaseri, Rajesh Kavia, et al.
American Journal of Respiratory and Critical Care Medicine|September 26, 2018
The Y Chromosome Regulates BMPR2 Expression via SRY: A Possible Reason "Why" Fewer Males Develop Pulmonary Arterial HypertensionLing Yan, Joy D Cogan, Lora K Hedges, et al.
Pulmonary Circulation|May 25, 2019
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertensionJames D West, Xinping Chen, Ling Ping, et al.
Lower Urinary Tract Symptoms|October 10, 2017
Female bladder outlet obstruction: Common symptoms masking an uncommon causeSachin Malde, Eskinder Solomon, Marco Spilotros, et al.
Pharmacoeconomics|December 21, 2014
Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspectiveRizwan Hamid, Clara Loveman, Jim Millen, et al.
Neurourology and Urodynamics|June 24, 2020
The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature reviewBogdan Toia, Mahreen H Pakzad, Rizwan Hamid, et al.
The Journal of Clinical Investigation|April 1, 2022
Lessons learned: next-generation sequencing applied to undiagnosed genetic diseasesBryce A Schuler, Erica T Nelson, Mary Koziura, et al.
Pageof 20